Invivyd, Inc.
Status: Publicly traded
Direct answer
Invivyd, Inc. is publicly traded on NASDAQ under the ticker IVVD.
Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of...
Can you invest in Invivyd, Inc.?
Yes. Invivyd, Inc. is publicly traded on NASDAQ under the ticker IVVD.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Invivyd, Inc.
Detailed equity research is provided by MarketSnap.